Sensei Biotherapeutics, Inc.
SNSE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $246 | $387 | $915 | $3,214 |
| - Cash | $10 | $13 | $18 | $7 |
| + Debt | $4 | $6 | $8 | $2 |
| Enterprise Value | $240 | $380 | $905 | $3,210 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$1 | -$2 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$30 | -$33 | -$47 | -$35 |
| % Margin | – | – | – | – |
| Net Income | -$30 | -$34 | -$49 | -$37 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.2 | -1.22 | -1.58 | -1.33 |
| % Growth | 1.6% | 22.8% | -18.8% | – |
| Operating Cash Flow | -$25 | -$32 | -$39 | -$30 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$2 |
| Free Cash Flow | -$25 | -$32 | -$39 | -$32 |